
|Articles|July 14, 2022
Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in Kids
Author(s)Miranda Hester
Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
Dermatology Times Spot Test: July 19, 2026
4
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD
5












